Pharmaceutical
Technology
Health

Galapagos

$102.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.68 (-0.66%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Galapagos and other stocks, options, ETFs, and crypto commission-free!

About

Galapagos NV American Depositary Shares, also called Galapagos, is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. Read More The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Employees
600
Headquarters
Mechelen, Brussels Region
Founded
1999
Market Cap
5.61B
Price-Earnings Ratio
โ€”
Dividend Yield
โ€”
Average Volume
108.85K
High Today
$103.01
Low Today
$101.38
Open Price
$102.15
Volume
39.92K
52 Week High
$122.28
52 Week Low
$85.00

Collections

Pharmaceutical
Technology
Health
Biotechnology
Research And Development
Europe (Non-UK)
Europe

News

Simply Wall St12h

The Galapagos (AMS:GLPG) Share Price Is Up 136% And Shareholders Are Boasting About It

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But when you pick a company that is really flourishing, you can make more than 100%. For instance the Galapagos NV (AMS:GLPG) share price is 136% higher than it was three years ago. How nice for those who held the stock! We note the stock price is up 3.7% in the last seven days. Check out our latest analysis for Galapagos Galapagos isnโ€™t a profitable company, so it is unlikely weโ€™...

11
Associated PressMar 20

Galapagos increases share capital through warrant exercises

This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. Mechelen, Belgium; 20 March 2019, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 149,370 new ordinary shares on 20...

7
The Motley FoolMar 9

3 Top Biotech Stocks to Buy in March

Biotech investors are having a great start to 2019. Shares of the SPDR S&P Biotech ETF are up 19% since Jan. 1, which is a heck of a run in such a short time. But which biotech stocks are worth a closer look during this recent rally? We asked three Motley Fool contributors to weigh in, and they picked Galapagos (NASDAQ:GLPG), Celgene (NASDAQ:CELG), and Zealand Pharma (NASDAQ:ZEAL). Big news is on deck for this clinical-stage biotech Todd Campbell: (Galapagos): This foreign-based biotech might not be on y...

664

Earnings

-$1.16
-$0.67
-$0.17
$0.32
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
โ€”
Actual
Available Apr 25, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.